{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:18:44Z","timestamp":1779905924729,"version":"3.53.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.amjms.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T04:00:36Z","timestamp":1473393636000},"page":"258-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Type B Insulin Resistance in Peru"],"prefix":"10.1016","volume":"353","author":[{"given":"Henry","family":"Zelada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Gamarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Arba\u00f1il","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helard","family":"Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2016.07.001_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.amjms.2016.07.001_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10067-012-2098-x","article-title":"Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review","volume":"32","author":"Zhang","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.amjms.2016.07.001_bib3","unstructured":"Pasquel M, Alvaro O, Nicolas J, et al. SAT-1034: Severe Acanthosis Nigricans and Diabetes Resolution after Immunosuppresion in Latin-American Female with Multiple Autoimmune Disorders."},{"issue":"2","key":"10.1016\/j.amjms.2016.07.001_bib4","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.amjms.2016.07.001_bib5","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"issue":"4209","key":"10.1016\/j.amjms.2016.07.001_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.170678","article-title":"Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance","volume":"190","author":"Fler","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.amjms.2016.07.001_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3904\/kjim.2013.28.1.98","article-title":"Type B insulin-resistance syndrome presenting as autoimmune hypoglycemia, associated with systemic lupus erythematosus and interstitial lung disease","volume":"28","author":"Kang","year":"2013","journal-title":"Korean J Intern Med"},{"issue":"9953","key":"10.1016\/j.amjms.2016.07.001_bib8","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0140-6736(14)61833-X","article-title":"Type B insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia","volume":"384","author":"Bourron","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjms.2016.07.001_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1756-185X.2009.01402.x","article-title":"Type B insulin resistance in a systemic lupus erythematosus patient","volume":"12","author":"Ostwal","year":"2009","journal-title":"Int J Rheumatic Dis"},{"issue":"3","key":"10.1016\/j.amjms.2016.07.001_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","article-title":"Acanthosis nigricans associated with insulin resistance","volume":"5","author":"Hermanns-L\u00ea","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2016.07.001_bib11","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1210\/jc.2014-3552","article-title":"Successful treatment of type B insulin resistance with rituximab","volume":"100","author":"Manikas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.amjms.2016.07.001_bib12","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1210\/jc.2010-1949","article-title":"Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman","volume":"96","author":"Mohammedi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjms.2016.07.001_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM200401153500324","article-title":"Rituximab therapy for the type B syndrome of severe insulin resistance","volume":"350","author":"Coll","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2016.07.001_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2169\/internalmedicine.49.2746","article-title":"Type B insulin resistance complicated with systemic lupus erythematosus","volume":"49","author":"Kawashiri","year":"2010","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.amjms.2016.07.001_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/diacare.21.8.1217","article-title":"Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance: case report","volume":"21","author":"Eriksson","year":"1998","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.amjms.2016.07.001_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5694\/j.1326-5377.2009.tb02335.x","article-title":"Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy","volume":"190","author":"Tran","year":"2009","journal-title":"Med J Aust"},{"issue":"12","key":"10.1016\/j.amjms.2016.07.001_bib17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ncpendmet0693","article-title":"A patient with type B insulin resistance syndrome, responsive to immune therapy","volume":"3","author":"Page","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.amjms.2016.07.001_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1464-5491.2005.01529.x","article-title":"Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus","volume":"22","author":"Coll","year":"2005","journal-title":"Diabetic Med"},{"issue":"8","key":"10.1016\/j.amjms.2016.07.001_bib19","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1210\/jc.2010-0167","article-title":"Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies","volume":"95","author":"Malek","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjms.2016.07.001_bib20","unstructured":"Pasquel M, Ontaneda A, Jara N, et al. SAT-1034: Severe Acanthosis Nigricans and Diabetes Resolution after Immunosuppresion in Latin-American Female with Multiple Autoimmune Disorders."}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915379593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915379593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:45:36Z","timestamp":1601070336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915379593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0002962915379593"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2016.07.001","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type B Insulin Resistance in Peru","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}